![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, March 14, 2015 12:33:54 PM
- Ongoing research collaborations with NASA and the Scripps Translational Science Institute prior to
first human trials of Acetone planned for April 2015
-The sensor will likely be sold to the HCP from the distributor
for less than $500
-One sensor can be used by all patients because of the replaceable
filter which prevents contamination of one patient to another.
- The monthly fee for the HCP will be
$30 for each disease application.
(Lets just say for argument sake they get up to 20 diseases..)
that's $30app x 20apps =$600 a Month per HCP or $7200/yr in fees per HCP
- Four Patents Issued and Two Pending
for this novel chemical sensing
nanotechnology
Look who put out the report as well...
http://nuviun.com/about
http://nuviun.com/digital-health/mhealth
Recent VNTH News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 09:30:06 PM
FEATURED ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • Jul 30, 2024 8:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • BLOZF • Jul 29, 2024 9:07 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM